{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T06:36:20Z","timestamp":1715150180899},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10096-020-03932-6","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T10:03:43Z","timestamp":1594202623000},"page":"2001-2002","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view"],"prefix":"10.1007","volume":"39","author":[{"given":"Farshad M.","family":"Shirazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shireen","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaneh","family":"Nakhaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Mehrpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"issue":"3","key":"3932_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/tmi.13383","volume":"25","author":"TP Velavan","year":"2020","unstructured":"Velavan TP, Meyer CG (2020) The COVID-19 epidemic. Tropical Med Int Health 25(3):278\u2013280","journal-title":"Tropical Med Int Health"},{"issue":"5","key":"3932_CR2","first-page":"H1084","volume":"318","author":"AM South","year":"2020","unstructured":"South AM, Diz DI, Chappell MC (2020) COVID-19, ACE2, and the cardiovascular consequences. Am J Phys Heart Circ Phys 318(5):H1084\u2013H1090","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"5","key":"3932_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3109\/15563650.2013.800875","volume":"51","author":"D Prasa","year":"2013","unstructured":"Prasa D, Hoffmann-Walbeck P, Barth S, Stedtler U, Ceschi A, F\u00e4rber E, Genser D, Seidel C, Deters M (2013) Angiotensin II antagonists\u2013an assessment of their acute toxicity. Clin Toxicol 51(5):429\u2013434","journal-title":"Clin Toxicol"},{"key":"3932_CR4","first-page":"m810","volume":"368","author":"R Sommerstein","year":"2020","unstructured":"Sommerstein R, Gr\u00e4ni C (2020) Rapid response: re: preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19. BMJ 368:m810","journal-title":"BMJ"},{"key":"3932_CR5","doi-asserted-by":"publisher","unstructured":"Sun ML, Yang JM, Sun YP, Su GH (2020) Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia. Zhonghua Jie He He Hu Xi Za Zhi 43(0):E014. https:\/\/doi.org\/10.3760\/cma.j.issn.1001-0939.2020.0014","DOI":"10.3760\/cma.j.issn.1001-0939.2020.0014"},{"key":"3932_CR6","first-page":"m406","volume":"368","author":"M Phadke","year":"2020","unstructured":"Phadke M, Saunik S (2020) Rapid response: use of angiotensin receptor blockers such as Telmisartan, Losartsan in nCoV Wuhan corona virus infections\u2014novel mode of treatment. BMJ 368:m406","journal-title":"BMJ"},{"issue":"10224","key":"3932_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395(10224):565\u2013574","journal-title":"Lancet"},{"issue":"17","key":"3932_CR8","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","volume":"382","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD (2020) Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with Covid-19. N Engl J Med 382(17):1653\u20131659","journal-title":"N Engl J Med"},{"issue":"2","key":"3932_CR9","first-page":"H137","volume":"310","author":"MC Chappell","year":"2016","unstructured":"Chappell MC (2016) Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute? Am J Phys Heart Circ Phys 310(2):H137\u2013H152","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"9","key":"3932_CR10","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.3390\/molecules25092076","volume":"25","author":"C Ciavarella","year":"2020","unstructured":"Ciavarella C, Motta I, Valente S, Pasquinelli G (2020) Pharmacological (or synthetic) and nutritional agonists of PPAR-\u03b3 as candidates for cytokine storm modulation in COVID-19 disease. Molecules 25(9):2076","journal-title":"Molecules"},{"issue":"2220","key":"3932_CR11","first-page":"30116","volume":"S2213-2600","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med S2213-2600(2220):30116\u201330118","journal-title":"Lancet Respir Med"},{"key":"3932_CR12","doi-asserted-by":"publisher","unstructured":"Danser AJ, Epstein M, Batlle D (2020) Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers. Hypertension 75. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.1120.15082","DOI":"10.1161\/HYPERTENSIONAHA.1120.15082"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03932-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-020-03932-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03932-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:02:59Z","timestamp":1623801779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-020-03932-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["3932"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-03932-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"assertion":[{"value":"14 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}